Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods Seite 1
02.12.2023 - VANCOUVER, BC / ACCESSWIRE / December 1, 2023 / Core One Labs Inc. ('Core One' or the 'Company') (CNSX:COOL)(OTCQB:CLABF)(Frankfurt:LD6) (WKN: A3CSSU), an emerging leader in the field of neuroscience and psychedelics, is delighted to share the ... Seite 1
Source: wallstreet-online.de